I agree that this site is using cookies. You can find further informations here.
X
Ontaneda, D.
496  results:
OpenAccess-fulltext X
Search for persons X
?
1

Dopamine Adsorption on Rutile TiO2(110): Geometry, Thermody..:

Cadmen, N ; Bustamante, J ; Rivera, R..
ACS Omega.  , 2022
Link: https://qmro.qmul.ac.uk/..
 
?
2

Decentralised clinical trials in multiple sclerosis researc:

Garjani, A ; Liu, BJ-Y ; Allen, CM...
doi:10.1177/13524585221100401.  , 2022
Link: https://doi.org/10.1177/..
 
?
3

Central vein sign: A diagnostic biomarker in multiple scler..:

Ontaneda, D ; Sati, P ; Raza, P...
qt2bp1v95x.  , 2021
Link: https://escholarship.org..
 
?
4

Central vein sign: A diagnostic biomarker in multiple scler..:

Ontaneda, D ; Sati, P ; Raza, P...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8482479/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
5

Polaron-Adsorbate Coupling at the TiO2(110)-Carboxylate Int..:

Tanner, AJ ; Wen, B ; Ontaneda, J...
J Phys Chem Lett.  , 2021
Link: https://qmro.qmul.ac.uk/..
 
?
6

Central vein sign: A diagnostic biomarker in multiple scler..:

D. Ontaneda ; P. Sati ; P. Raza...
http://www.sciencedirect.com/science/article/pii/S2213158221002783.  , 2021
Link: https://doi.org/10.1016/..
 
?
7

Polaron-Adsorbate Coupling at the TiO₂(110)-Carboxylate Int..:

Tanner, AJ ; Wen, B ; Ontaneda, J...
https://discovery.ucl.ac.uk/id/eprint/10126083/1/acs.jpclett.1c00678.pdf.  , 2021
Link: https://discovery.ucl.ac..
 
?
8

Determining the effectiveness of early intensive versus esc..:

Ontaneda, D ; Tallantyre, E ; Raza, P...
doi:10.1016/j.cct.2020.106009.  , 2020
Link: https://doi.org/10.1016/..
 
?
9

Adsorption of Aspartic Acid on Ni{100}: A Combined Experime..:

Quevedo, W ; Ontaneda, J ; Large, A...
Langmuir.  , 2020
Link: https://qmro.qmul.ac.uk/..
 
?
10

El crecimiento cantonal en el Ecuador y el papel de la hete..:

PONTAROLLO N ; Mendieta Muñoz R ; ONTANEDA D
volume:129.  , 2019
Link: http://hdl.handle.net/11..
 
?
11

Canton growth in Ecuador and the role of spatial heterogene..:

Pontarollo, N ; Mendieta, R ; Ontaneda, D
info:eu-repo/semantics/altIdentifier/wos/WOS:000510393600007.  , 2019
Link: http://hdl.handle.net/11..
 
?
12

Imaging outcome measures of neuroprotection and repair in M..:

Oh J ; Ontaneda D ; Azevedo C...
info:eu-repo/semantics/altIdentifier/pmid/30787160.  , 2019
Link: http://hdl.handle.net/11..
 
?
13

Design and rationale of the determining the effectiveness o..:

Ontaneda, D ; Tallantyre, E ; Nakamura, K...
doi:10.1177/1352458518798590.  , 2018
Link: https://doi.org/10.1177/..
 
?
14

Progressive multiple sclerosis: Prospects for disease thera..:

Thompson, AJ ; Ontaneda, D ; Fox, RJ.
https://discovery.ucl.ac.uk/id/eprint/1507827/1/Thompson_Ontaneda%20et%20al_Progr%20MS%20review_final_clean_w%20figures_09JUL2016.pdf.  , 2017
Link: https://discovery.ucl.ac..
 
?
15

Measuring Myelin Repair and Axonal Loss with Diffusion Tens..:

Fox, R.J ; Cronin, T ; Lin, J...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7964935/.  , 2011
Link: http://www.ncbi.nlm.nih...
 
1-15